Prosecution Insights
Last updated: October 04, 2026

Treasure Ip Group

Technology areas: Biotechnology & Pharmaceuticals • Communications • Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering

5 pending office actions • 5 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 36 patents granted in the last 365 days

Analysis

Treasure IP Group focuses on Medical Devices & Mechanical Engineering with 534 career applications. The firm maintains a resolved allowance rate pct of 90.66, indicating a high success rate for closed cases. Practitioners manage an avg_office_actions_per_allowance of 2.49, which reflects the typical effort required to reach an allowance in this technical field. This metric provides a baseline for clients to estimate the duration of the examination process.

Currently, the firm has 5 pending office actions to address. This volume of active work is small relative to the 534 career applications handled by the group, suggesting a stable current workload. The 90.66 resolved allowance rate pct suggests a predictable outcome for clients seeking patent protection in mechanical sectors. With 2.49 avg_office_actions_per_allowance, the firm demonstrates a consistent prosecution cycle that balances thoroughness with efficiency. These data points together illustrate a practice with a strong track record in its primary technology area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=534 apps, methodology: how we score firms)

90.5%
Allowance Rate
n=534
+0.50σ
Allowance Rate (norm)
n=534
2.5
OAs to Allowance
n=439
-0.47σ
OAs to Allow (norm)
n=439
848 days
Time to Allowance
n=439
+8.6pp
Interview Lift
n=534
11.6%
RCE Rate
n=534
0.3%
Appeal Rate
n=534

Rejection Performance (% of received rejections ultimately overcome)

73.0%
§101 Overcome
n=37
83.7%
§102 Overcome
n=135
83.1%
§103 Overcome
n=266
86.6%
§112 Overcome
n=269

Specialization & Scale

A61B, H10D, H01L
Top CPC Subclasses
21%
Top-3 CPC Share
n=534
0
Practitioners
n=534
—
Apps / Practitioner
n=534 (min 20)

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (20%)
3
Medium (60%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (60%)
§112 only1 (20%)
Multi-statute (no §101)1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
20% of docket
0
Information Tech
0% of docket
2
Communications
40% of docket
1
Semiconductors
20% of docket
1
Mechanical / Eng
20% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILSON, DOUGLAS M 1 75.3% +14.7%
OAKES, JUSTIN MONTGOMERY 1 — —
SAHAND, SANA 1 63.4% +23.8%
RIVERA-PEREZ, CARLOS O 1 72.4% +19.6%
GROOMS, TIFFANY NICOLE 1 57.8% +46.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19124211 OLED DISPLAY DEVICE AND TEMPERATURE PROTECTION DEVICE AND METHOD THEREOF WILSON, DOUGLAS M —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17911130 GENE INTERFERENCE VECTOR- AND IRON NANOPARTICLE-BASED COMPOSITION FOR KILLING CANCER CELLS, AND USE THEREOF GROOMS, TIFFANY NICOLE 30d overdue
18722552 CAPSULE ENDOSCOPE IMAGING DEVICE, METHOD, AND CAPSULE ENDOSCOPE SAHAND, SANA 10d overdue
18478829 Protection Circuit of Flyback Converter and Control Method RIVERA-PEREZ, CARLOS O 9d overdue
19124211 OLED DISPLAY DEVICE AND TEMPERATURE PROTECTION DEVICE AND METHOD THEREOF WILSON, DOUGLAS M —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
26221
26621
37961
28381
16371

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19124211 OLED DISPLAY DEVICE AND TEMPERATURE PROTECTION DEVICE AND METHOD THEREOF Chipone Technology (Zhuhai) Co., Ltd. WILSON, DOUGLAS M 2622 §102§103 Non-Final OA — Pending Apr 24, 2025
18574023 ENDOSCOPIC IMAGE RECOGNITION METHOD, ELECTRONIC DEVICE, AND STORAGE MEDIUM Anxip Holding Pte. Ltd. OAKES, JUSTIN MONTGOMERY 2662 §103 Non-Final OA — Pending Jul 23, 2024
18722552 CAPSULE ENDOSCOPE IMAGING DEVICE, METHOD, AND CAPSULE ENDOSCOPE Ankon Medical Technologies (Shanghai) Co., Ltd. SAHAND, SANA 3796 §103Other Final Rejection 10d overdue Pending Jun 20, 2024
18478829 Protection Circuit of Flyback Converter and Control Method Joulwatt Technology Co., Ltd. RIVERA-PEREZ, CARLOS O 2838 §103 Final Rejection 9d overdue Pending Sep 29, 2023
17911130 GENE INTERFERENCE VECTOR- AND IRON NANOPARTICLE-BASED COMPOSITION FOR KILLING CANCER CELLS, AND USE THEREOF Southeast University GROOMS, TIFFANY NICOLE 1637 §112 Final Rejection 30d overdue Pending Sep 12, 2022

Managing Treasure Ip Group's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month